Best High Tech Stocks To Buy Right Now

Best High Tech Stocks To Buy Right Now: Valeant Pharmaceuticals International Inc(VRX)

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was fou! nded in 1960 and is headquartered in M ississauga, Canada.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Allergan (NYSE: AGN) shares were also up, gaining 15.61 percent to $164.16 on buyout offer from Valeant Pharmaceuticals International (NYSE: VRX).

• [By Jesse Solomon]

  Outside of earnings, a mega pharmaceutical deal emerged late Monday. Shares in Botox maker Allergan (AGN, Fortune 500)surged 16% after activist investor Bill Ackman (Allergan's largest shareholder) said he approved of Valeant Pharmaceutical (VRX)'s bid to buy the company. Allergan had already gained 6% on Monday.

• [By Johanna Bennett]

  Citing unnamed sources, the WSJ reports that Ackman could be setting up Zoetis as a a fallback plan for Valeant Pharmaceuticals (VRX) if it fails to buy Allergan (AGN)

• [By Sean Williams]

  What: Shares of Hyperion Therapeutics (NASDAQ: HPTX  ) , a biopharmaceutical company focused on treatments for orphan diseases and hepatology, rose as much as 10% after receiving orphan drug exclusivity status for Ravicti from the Food and Drug Administration, and exercising an option to acquire two additional urea cycle drugs from Valeant Pharmaceuticals (NYSE: VRX  ) .

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/best-high-tech-stocks-to-buy-right-now-2.html